HSBC Holdings
SANA icon

HSBC Holdings’s Sana Biotechnology SANA Stock Holding History

HSBC Holdings’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$205K Sell
72,194
-21,870
-23% -$86.1K ﹤0.01% 2602
2025
Q4 		$375K Buy
94,064
+15,836
+20% +$70.9K ﹤0.01% 2431
2025
Q3 		$269K Buy
78,228
+52,487
+204% +$190K ﹤0.01% 2372
2025
Q2 		$74.8K Sell
25,741
-15,636
-38% -$32.3K ﹤0.01% 2890
2025
Q1 		$64.7K Buy
41,377
+8,673
+27% +$24.2K ﹤0.01% 2875
2024
Q4 		$52.5K Buy
32,704
+19,084
+140% +$56.9K ﹤0.01% 2981
2024
Q3 		$57.3K Buy
+13,620
New +$71.6K ﹤0.01% 2869
2024
Q2 		– Sell
-11,840
Closed -$118K – 3143
2024
Q1 		$118K Buy
+11,840
New +$88.7K ﹤0.01% 2813
2023
Q4 		– Sell
-19,540
Closed -$75.3K – 2892
2023
Q3 		$75.3K Buy
+19,540
New +$105K ﹤0.01% 2587
2022
Q3 		– Sell
-11,047
Closed -$71K – 3221
2022
Q2 		$71K Hold
11,047
– – ﹤0.01% 3095
2022
Q1 		$90K Buy
+11,047
New +$89.3K ﹤0.01% 3139

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

HSBC Holdings's SANA Position: Q1 2026 in Review

HSBC Holdings reduced its Sana Biotechnology (SANA) stake by 23% in Q1 2026, selling an estimated $86.1K and leaving 72,194 shares worth $205K. The position accounts for ﹤0.01% of the portfolio, ranked #2602.

HSBC Holdings first reported a position in SANA in Q1 2022 and has held it in 11 quarters since. The position peaked at $375K in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • HSBC Holdings held 72,194 shares of Sana Biotechnology worth $205K as of Q1 2026.
  • HSBC Holdings sold 21,870 Sana Biotechnology shares in Q1 2026, an estimated $86.1K.
  • Sana Biotechnology made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2602 holding.
  • HSBC Holdings first reported a position in Sana Biotechnology in Q1 2022 and has held it in 11 quarters since.
  • HSBC Holdings's Sana Biotechnology position peaked at $375K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.